- Home
- SOPA vs EVOK Comparison
SOPA vs EVOK Comparison
Compare SOPA & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- EVOK
- Stock Information
- Founded
- SOPA 2018
- EVOK 2007
- Country
- SOPA Singapore
- EVOK United States
- Employees
- SOPA N/A
- EVOK N/A
- Industry
- SOPA EDP Services
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- EVOK Health Care
- Exchange
- SOPA Nasdaq
- EVOK Nasdaq
- Market Cap
- SOPA 6.3M
- EVOK 7.1M
- IPO Year
- SOPA 2021
- EVOK 2013
- Fundamental
- Price
- SOPA $1.73
- EVOK $5.07
- Analyst Decision
- SOPA Buy
- EVOK
- Analyst Count
- SOPA 2
- EVOK 0
- Target Price
- SOPA $16.00
- EVOK N/A
- AVG Volume (30 Days)
- SOPA 10.2M
- EVOK 8.5K
- Earning Date
- SOPA 04-14-2025
- EVOK 03-13-2025
- Dividend Yield
- SOPA N/A
- EVOK N/A
- EPS Growth
- SOPA N/A
- EVOK N/A
- EPS
- SOPA N/A
- EVOK N/A
- Revenue
- SOPA $6,906,240.00
- EVOK $8,617,036.00
- Revenue This Year
- SOPA $7.97
- EVOK $97.35
- Revenue Next Year
- SOPA $93.06
- EVOK $99.52
- P/E Ratio
- SOPA N/A
- EVOK N/A
- Revenue Growth
- SOPA N/A
- EVOK 100.35
- 52 Week Low
- SOPA $0.73
- EVOK $3.54
- 52 Week High
- SOPA $6.75
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- SOPA 45.87
- EVOK 55.10
- Support Level
- SOPA $1.63
- EVOK $4.68
- Resistance Level
- SOPA $6.30
- EVOK $5.40
- Average True Range (ATR)
- SOPA 1.08
- EVOK 0.31
- MACD
- SOPA -0.16
- EVOK 0.03
- Stochastic Oscillator
- SOPA 1.95
- EVOK 57.85
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.